Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO ...Middle East

BEIJING and SHANGHAI and CHICAGO, June 1, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, presented updated data of a KRAS G12C inhibitor glecirasib (JAB-21822) in combination with a SHP2 inhibitor (JAB-3312) in frontline...

Hence then, the article about jacobio pharma presents shp2 plus kras g12c data at asco was published today ( Sunday 02/06/2024 - 03:40 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO )

Also on site :

• Crews respond to large fire at Denny Hamlin's parents' house in Stanley: Sources
• Reported tornado rips roofs off multiple homes in central Illinois
• John Legend Celebrates 47th Birthday With Family Slime Outing in New York